Trial Profile
A Randomized, Double-blind, Adjuvant-controlled Phase 1a/b Study on Safety and Tolerability With Ascending Multiple Doses of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Mar 2022
Price :
$35
*